SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    American Cancer Society. Cancer Facts and Figures—2001. 5008.01. Atlanta, Ga: American Cancer Society; 2001.
  • 2
    American College of Physicians. Clinical guideline: screening for prostate cancer. Ann Intern Med. 1997;126: 4804.
  • 3
    Office of Technology Assessment. Costs and effectiveness of prostate cancer screening in elderly men. OTA-BP-H-145. Washington DC: U.S. Government Printing Office; 1995.
  • 4
    Smith RA, Cokkinides V, Eyre HJ. American Cancer Society Guidelines for the Early Detection of Cancer, 2003. CA Cancer J Clin. 2003;53: 2743.
  • 5
    U.S. Preventive Services Task Force. Screening for prostate cancer: recommendation and rationale. Ann Intern Med. 2002;137: 9156.
  • 6
    Wilkins EG, Lowery JC, Hamill JB. Patient preferences in PSA screening: the impact of shared decision-making videos. Abstract presented at the 17th annual VA Health Sciences Research and Development Meeting, Washington, DC . 1999.
  • 7
    Frosch DL, Kaplan RM, Felitti V. Evaluation of two methods to facilitate shared decision making for men considering the prostate-specific antigen test. J Gen Intern Med. 2001;16: 3918.
  • 8
    Volk RJ, Cass AR, Spann SJ. A randomized controlled trial of shared decision making for prostate cancer screening. Arch Fam Med. 1999;8: 33340.
  • 9
    Flood AB, Wennberg JE, Nease RF Jr, Fowler FJ Jr, Ding J, Hynes LM. The importance of patient preference in the decision to screen for prostate cancer. J Gen Intern Med. 1996;11: 3429.
  • 10
    Wolf AMD, Nasser JF, Wolf AM, Schorling JB. The impact of informed consent on patient interest in prostate-specific antigen screening. Arch Intern Med. 1996;156: 13336.
  • 11
    Schapira MM, VanRuiswyk J. The effect of an illustrated pamphlet decision-aid on the use of prostate cancer screening tests. J Fam Pract. 2000;49: 41824.
  • 12
    Wilt TJ, Paul J, Murdoch M, Nelson D, Nugent S, Rubins H. Educating men about prostate cancer screening: a randomized trial of a mailed pamphlet. Eff Clin Pract. 2001;4: 11220.
  • 13
    Davison BJ, Kirk P, Degner LF, Hassard TH. Information and patient participation in screening for prostate cancer. Patient Educ Couns. 1999;37: 25563.
  • 14
    Bandura A. Social Foundations of Thought and Action: A Social Cognitive Theory. 13th ed. New Jersey: Prentice-Hall; 1986.
  • 15
    Partin MR, Dillon N, Haas M, Wilt TJ.“The PSA Test for Prostate Cancer: Is It Right for ME?”Minneapolis, Minn: Minneapolis VA Medical Center; 2002.
  • 16
    Radosevich DM, Partin MR, Nugent S, et al. Measuring patient knowledge of the risks and benefits of prostate cancer screening. Patient Educ Couns. 2004;54: in press.
  • 17
    Barry MJ, Fowler FJ Jr, O'Leary MP, et al. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol. 1992;148: 154957.
  • 18
    Rosenbaum PR, Rubin DR. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70: 415.
  • 19
    Partin MR, Wilt , TJ. Informing patients about prostate cancer screening: identifying and meeting the challenges while the evidence remains uncertain. Am J Med. 2002;113: 6913.